Download PDF
Arthritis und Rheuma 2022; 42(04): 241-246
DOI: 10.1055/a-1883-0988
Schwerpunkt

Idiopathische rekurrierende Perikarditis

Idiopathic recurrent pericarditis
Martin Krusche
1   Universitätsklinikum Hamburg-Eppendorf, III. Medizinische Klinik und Poliklinik für Nephrologie, Rheumatologie und Endokrinologie
,
Nikolas Ruffer
1   Universitätsklinikum Hamburg-Eppendorf, III. Medizinische Klinik und Poliklinik für Nephrologie, Rheumatologie und Endokrinologie
› Author Affiliations
› Further Information
    Permissions and Reprints

ZUSAMMENFASSUNG

Die idiopathische rekurrierende Perikarditis (IRP) umfasst rezidivierende Perikarditis-Episoden, für die keine anderen Ursachen bzw. Auslöser gefunden werden können. Aufgrund ihres inflammatorischen Charakters (meist akute Schmerzattacken mit deutlich erhöhten serologischen Entzündungszeichen sowie gutem Ansprechen auf Colchicin und/oder Interleukin-1-Blockade) mit Rezidivneigung wird die Erkrankung auch als eigenständige autoinflammatorische Erkrankung angesehen. Darüber hinaus können vergleichbare Episoden auch bei anderen autoinflammatorischen Erkrankungen wie dem familiären Mittelmeerfieber (FMF) oder TNF-Rezeptor-assoziierten periodischen Syndrom (TRAPS) auftreten. Der Artikel gibt einen Überblick über die Klinik, Pathophysiologie und Therapie der IRP.

ABSTRACT

Idiopathic recurrent pericarditis (IRP) refers to episodes of recurrent pericarditis for which no other causes or triggers can be identified. Due to the inflammatory character (acute attacks of thoracic pain with increased serological inflammatory markers and a good response to colchicine and/or interleukin-1-blockade) with a tendency to recurrence, the disease is considered an autoinflammatory disease. In addition, comparable episodes can also be other autoinflammatory diseases such as familial Mediterranean fever (FMF) or TNF receptor-associated periodic syndrome (TRAPS). This article provides an overview of the clinic, pathophysiology, and therapy of IRP.

Schlüsselwörter

Autoinflammation - familiäres Mittelmeerfieber - TRAPS - IL-1-Blockade

Keywords

Autoinflammation - Familial Mediterranean Fever - TRAPS - IL-1-blockage


Publication History

Article published online:
07 September 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Krusche M, Schneider U, Ruffer N. [Pericarditis is inflammation of the pericardium, which rheumatologists should know]. Z Rheumatol 2021; 80: 54-64
    CrossrefPubMedGoogle Scholar
  • 2 Imazio M. et al Anti-interleukin-1 agents for pericarditis: a primer for cardiologists. Eur Heart J ehab 452 2021; DOI: 10.1093/eurheartj/ehab452.
    CrossrefPubMedGoogle Scholar
  • 3 Imazio M. et al Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study. Circulation 2013; 128: 42-49
    CrossrefPubMedGoogle Scholar
  • 4 Cremer PC. et al Complicated Pericarditis: Understanding Risk Factors and Pathophysiology to Inform Imaging and Treatment. J Am Coll Cardiol 2016; 68: 2311-2328
    CrossrefPubMedGoogle Scholar
  • 5 Imazio M. et al Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med 2011; 155: 409-414
    CrossrefPubMedGoogle Scholar
  • 6 Imazio M, Gaita F, LeWinter M. Evaluation and Treatment of Pericarditis: A Systematic Review. JAMA 2015; 314: 1498-1506
    CrossrefPubMedGoogle Scholar
  • 7 Permanyer-Miralda G, Sagristá-Sauleda J, Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol 1985; 56: 623-630
    CrossrefPubMedGoogle Scholar
  • 8 Maestroni S. et al Recurrent pericarditis: autoimmune or autoinflammatory?. Autoimmun Rev 2012; 12: 60-65
    CrossrefPubMedGoogle Scholar
  • 9 Ozen S. et al Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children. Ann Rheum Dis 2014; 73: 662-667
    CrossrefPubMedGoogle Scholar
  • 10 Peet CJ. et al Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis and Monogenic Autoinflammatory Diseases at a National Referral Center. J Am Heart Assoc 11: e024931 2022;
    CrossrefPubMedGoogle Scholar
  • 11 Lachmann HJ. et al The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry. Ann Rheum Dis 2014; 73: 2160-2167
    CrossrefPubMedGoogle Scholar
  • 12 Cantarini L, Lucherini OM, Baldari CT. et al Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome. Clin Exp Rheumatol 2010; 28: 405-407
    PubMedGoogle Scholar
  • 13 Cantarini L. et al Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. Clin Res Cardiol Off J Ger Card Soc 2012; 101: 525-531
    CrossrefPubMedGoogle Scholar
  • 14 Cantarini L. et al The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up. Semin. Arthritis Rheum 2014; 43: 818-823
    CrossrefPubMedGoogle Scholar
  • 15 Kontzias A. Idiopathic Recurrent Acute Pericarditis. In: Efthimiou P, ed. Auto-Inflammatory Syndromes: Pathophysiology, Diagnosis, and Management. Springer International Publishing 2019 DOI: 10.1007/978-3-319-96929-9
    CrossrefGoogle Scholar
  • 16 Ristić AD, Pankuweit S, Maksimović R. et al Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis. Heart Fail Rev 2013; 18: 345-353
    CrossrefPubMedGoogle Scholar
  • 17 Lazaros G. et al The role of the immunogenetic background in the development and recurrence of acute idiopathic pericarditis. Cardiology 2011; 118: 55-62
    CrossrefPubMedGoogle Scholar
  • 18 Adler Y. et al 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015; 36: 2921-2964
    CrossrefPubMedGoogle Scholar
  • 19 Boyadzhieva Z, Ruffer N, Krusche M. Colchicin: altes Medikament mit neuem Nutzen: Einsatz in der Rheumatologie und darüber hinaus. Z Rheumatol 2021; 80: 647-657
    CrossrefPubMedGoogle Scholar
  • 20 Imazio M. et al Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation 2005; 112: 2012-2016
    CrossrefPubMedGoogle Scholar
  • 21 Imazio M. et al A randomized trial of colchicine for acute pericarditis. N Engl J Med 2013; 369: 1522-1528
    CrossrefPubMedGoogle Scholar
  • 22 Imazio M. et al Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet Lond Engl 2014; 383: 2232-2237
    CrossrefPubMedGoogle Scholar
  • 23 Vianello F. et al Azathioprine in isolated recurrent pericarditis: a single centre experience. Int J Cardiol 2011; 147: 477-478
    CrossrefPubMedGoogle Scholar
  • 24 Imazio M. et al Intravenous human immunoglobulins for refractory recurrent pericarditis: a systematic review of all published cases. J Cardiovasc Med 2016; 17: 263-269
    PubMedGoogle Scholar
  • 25 Lo Presti S. et al Emerging Therapies for Recurrent Pericarditis: Interleukin-1 inhibitors. J Am Heart Assoc 2021; 10: e021685
    CrossrefPubMedGoogle Scholar
  • 26 Imazio M. et al Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study. Eur J. Prev Cardiol 2020; 27: 956-964
    CrossrefPubMedGoogle Scholar
  • 27 Klein A. et al Rilonacept in recurrent pericarditis: first efficacy and safety data from an ongoing phase 2 pilot clinical trial. J Am Coll Cardiol 2019; 73: 1261
    CrossrefPubMedGoogle Scholar
  • 28 Gillaspie EA. et al A 20-year experience with isolated pericardiectomy: Analysis of indications and outcomes. J Thorac Cardiovasc Surg 2016; 152: 448-458
    CrossrefPubMedGoogle Scholar